EGFR and non-small cell lung carcinoma: Hence, we designed a research study to explore the role of candidate plasma miRNAs (miR-21, miR-27a, and miR-181a) as a surrogate for predicting EGFR-TKIs performance in advanced EGFR-mutated NSCLC patients (DynaMiR Study).